Search Results for: IONI

Americans Just Aren’t Listening to Doctors and Nutritionists, Study Finds

For decades, everyone from medical researchers to academic nutritionists to pop-culture dieticians has been telling us the same thing: For longer, healthier lives, eat less processed meat and consume more ...
Read Full Story »

This City Is Auctioning Off Hundreds of Homes for $1,000 Each

Several American cities remain so blighted that they have thousands of unoccupied houses. Some of these houses have been bulldozed; others have been left to rot. In one city, the ...
Read Full Story »

17 Things Nutritionists Want You to Know About Calories

Most people have some history with calorie counting. Some do it to lose extra pounds, others track them to gain weight. Calories -- depending on whether they come from carbs, ...
Read Full Story »

Meet Ionis Pharma’s Newest Collaboration

Ionis Pharmaceuticals Inc. (NASDAQ: IONS) shares were relatively flat on Wednesday after the company announced a new collaboration with Roche to develop IONIS-FB-LRx for the treatment of complement-mediated diseases. Ultimately, ...
Read Full Story »

Inside Apple’s A12 Bionic

Apple is first to market with a mass-produced 7mm system on a chip.   From Anantech’s Andrei Frumusana: We break down the individual IP block sizes alongside the total ...
Read Full Story »

Akcea and Ionis Pharma Win Big in Midstage Cardiovascular Disease Study

Akcea Therapeutics Inc. (NASDAQ: AKCA) and Ionis Pharmaceuticals Inc. (NASDAQ: IONS) shares made a solid gain on Monday after the companies announced positive top-line data for a midstage trial in ...
Read Full Story »

Why Akcea and Ionis Are Getting Crushed

Akcea Therapeutics Inc. (NASDAQ: AKCA) and Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) were each crushed on Tuesday after each announced that it received a Complete Response Letter (CRL) from U.S. Food ...
Read Full Story »

Demand for Electricity to Be Driven by Demand for Air Conditioning

Between now and 2050, global demand for air conditioners in buildings will rise from 1.6 billion to 5.6 billion. That means that 10 new AC units will be sold every ...
Read Full Story »

How Short Sellers Were Positioning Ahead of Zuckerberg’s Testimony

Social media has taken the world by storm, building virtual communities for anyone who has internet access and allowing people to connect and share across the globe. Many of these ...
Read Full Story »

Why Ionis Pharma Is Sinking Despite Solid Late-Stage Results

Ionis Pharmaceuticals Inc. (NASDAQ: IONS) saw its shares pullback on Monday morning after results were released from its late-stage trial for the treatment of familial amyloid polyneuropathy. Although the results ...
Read Full Story »
Tesla factory

Are Tesla Workers Getting Ready to Unionize?

Early last year, the United Auto Workers (UAW) labor union began talking with employees at Tesla Inc.'s (NASDAQ: TSLA) Fremont, California, plant to determine if there was interest in having the ...
Read Full Story »
yacht flag

America’s Cup Revolutionizes Its Future, Loosens Oracle Billionaire Larry Ellison’s Grip

Team owners who want to spend the tens of millions of dollars to enter the America's Cup face a wall of challenges. The rules of the competition may be changed, ...
Read Full Story »
buy sell

Top Analysts Upgrades and Downgrades: Biogen, FedEx, Lions Gate, Rexnord, Ionis Pharmaceutical and More

With just one trading week left for 2016, and a shortened one at that due to the market holiday yesterday, investors will be making some final changes, perhaps doing some ...
Read Full Story »
money

Ionis Pharmaceuticals Rises Despite Missing Earnings

Ionis Pharmaceuticals Inc. (NASDAQ: IONS) reported its third-quarter financial results before the markets opened on Wednesday. The company posted $0.06 in earnings per share (EPS) and $110.9 million in revenue. ...
Read Full Story »
baby boy's feet

How Biogen and Ionis Won Big (and Can Win More) From Late Stage Trial

Shares of Biogen Inc. (NASDAQ: BIIB) and, especially, Ionis Pharmaceuticals Inc. (NASDAQ: IONS) made handy gains early Monday morning following favorable interim results from a late-stage trial. The companies announced that nusinersen, ...
Read Full Story »